Document is current
Any future updates will be listed below
-
Authors
Makita, Shinichi https://orcid.org/0000-0001-6609-8088
Izutsu, Koji
Mishima, Yuko
Kumode, Takahiro
Kuroda, Junya
Kanemura, Nobuhiro
Fukuhara, Noriko
Shimada, Kazuyuki
Mori, Chiemi
Kawasaki, Atsuko
Miyake, Takeshi
Maruyama, Dai
-
Funding
Funding for this research was provided by:
Chugai Pharmaceutical Co., Ltd
- License Information
-
More Information
Article History
Received: 29 October 2025
Accepted: 24 December 2025
First Online: 12 January 2026
Declarations
:
: SM: Honoraria: Bristol-Myers Squibb, Chugai Pharmaceutical Co., Ltd, Genmab, Gilead Science; KI: AstraZeneca, AbbVie, Incyte, Bristol-Myers Squibb, Novartis, Daiichi Sankyo, Chugai Pharmaceutical Co., BeiGene, Genmab, LOXO Oncology, Regeneron; YM: No disclosures to report; TK: Honoraria: Chugai Pharmaceutical Co., Ltd, Janssen, Ono Pharmaceuticals, AbbVie, Genmab, AstraZeneca, BeOne; JK: Honoraria: BeOne, Janssen, Kyowa Kirin, Bristol-Myers Squibb, Asahi Kasei, Astellas, AstraZeneca, Eisai, Pfizer, Otsuka Pharmaceutical, Sanofi, Ono Pharmaceutical, Novartis, AbbVie, Chugai Pharmaceutical Co., Ltd, Daiichi Sankyo, Nippon Shinyaku, Genmab, Amgen. Fees for promotional materials: Chugai Pharmaceutical Co., Ltd, Eisai, Pfizer. Research funding: Taiho Pharmaceutical, Chugai Pharmaceutical Co., Ltd, Mochida Pharmaceutical, Asahi Kasei, Janssen, AbbVie, MSD, Bristol-Myers Squibb, Pfizer, Otsuka Pharmaceutical, Takeda Pharmaceutical, Ono Pharmaceutical, BeOne, and Regeneron; NK: Honoraria: Chugai Pharmaceutical Co., Ltd; NF: Honoraria: Bristol-Myers Squibb, Chugai Pharmaceutical Co., Ltd; KS: Honoraria: Chugai Pharmaceutical Co., Ltd, Eli Lilly, AbbVie, BeiGene, Genmab, Daiichi Sankyo, Ohara, Takeda, Kyowa Kirin, CSL Behring, Eisai, Janssen, Bristol-Myers Squibb, Nippon Shinyaku, Ono, Gilead, Novartis, Incyte, Meiji Seika Pharma, Mundi Pharma, Sanofi, Taisho, IQVIA, Asahi Kasei. Research funding: Kyowa Kirin; CM: Employee of Chugai Pharmaceutical Co., Ltd. Stock ownership: Chugai Pharmaceutical Co., Ltd; AK: Employee of Chugai Pharmaceutical Co. Ltd; TM: Employee of Chugai Pharmaceutical Co., Ltd. Stock ownership: Chugai Pharmaceutical Co., Ltd. Patent licensing fees: Chugai Pharmaceutical Co., Ltd; DM: Honoraria: Ono, Nippon Shinyaku, Janssen, Mundi Pharma, Eisai, Chugai Pharmaceutical Co., Ltd, Kyowa Kirin, MSD, Sanofi, Symbio, Takeda, AbbVie, AstraZeneca, Bristol-Myers Squibb, Genmab, Novartis, Pfizer. Research funding: Ono, Janssen, Eisai, Chugai Pharmaceutical Co., Ltd, Kyowa Kirin, MSD, Sanofi, Symbio, Takeda, AbbVie, AstraZeneca, Bristol-Myers Squibb, Genmab, Novartis, Otsuka, Taiho, Pfizer, Astellas.
